TRxADE HEALTH, Inc. (MEDS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:25PM EDT. Market open.
| Previous close | 6.66 |
| Open | 6.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 6.25 - 6.55 |
| 52-week range | 3.69 - 44.56 |
| Volume | |
| Avg. volume | 437,741 |
| Market cap | 7.893M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 2024 |
| 1y target est | N/A |
- Zacks
TRxADE (MEDS) Reports Q1 Loss, Lags Revenue Estimates
TRxADE (MEDS) delivered earnings and revenue surprises of -50% and 8.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Similar Genomics Systems (OMIC) Reports Q1 Loss, Lags Revenue Estimates
Similar Genomics Systems (OMIC) delivered earnings and revenue surprises of 2.94% and 39.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
TRxADE (MEDS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
TRxADE (MEDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.